Table 1.

Clinical value of novel bladder tumor markers.

Combinations/Novel Markers	Value	Reference
Cytology ± FISH ± uCyt™ ± NMP22	Diagnosis	Todenhoffer et al. 2013 [13]
Cytology ± Survivin ± MMP	Diagnosis	Eissa et al. 2013 [15]
Cytology ± Survivin ± Hyaluronidase	Diagnosis	Eissa et al. 2013 [14]
Cystoscopy ± NMP22 ± FISH	Surveillance	Kamat et al. 2011 [16]
Nicotinamide N-Methyltransferase	Diagnosis	Sartini et al. 2013 [17]
P-Cadherin	Prognosis	Wang et al. 2014 [18]
EpCAM	Prognosis	Bryan et al. 2014 [19]
miR 130b + 141+ 199-3p + 205	Diagnosis	Ratert et al. 2013 [20]
miR 141	Prognosis	Ratert et al. 2013 [20]
miR 205	Prognosis	Ratert et al. 2013 [20]
miR 29c*	Prognosis	Rosenberg et al. 2013 [21]
miR 187 + 18a* + 25 + 142-3p + 140-5p + 204	Diagnosis and Prognosis	Mengual et al. 2013 [22]